Xenograft tumors vascularized with murine blood vessels may overestimate the effect of anti-tumor drugs: A pilot study

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Dong, Zhihong ^a   Imai, Atsushi ^a   Krishnamurthy, Sudha ^a   Zhang, Zhaocheng ^a   Zeitlin, Benjamin D ^a   Nör, Jacques E ^a,b,c,d  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b University of Michigan   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BLOOD VESSELS; CELL PROLIFERATION; CISPLATIN; ENDOTHELIAL CELLS; HETEROGRAFTS; HUMANS; INDOLES; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PILOT PROJECTS; PYRROLES; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TISSUE ENGINEERING; TUMOR MICROENVIRONMENT;

EID: 84894121821     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084236     Document Type: Article

References (30)

1. Fiebig HH, Maier A, Burger AM (2004) Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery. Eur J Cancer 40: 802-820. (Pubitemid 38519759)
2. Morton CL, Houghton PJ (2007) Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc 2: 247-250. (Pubitemid 47040037)
3. Mischek D, Steinborn R, Petznek H, Bichler C, Zatloukal K, et al. (2009) Molecularly characterized xenograft tumour mouse models: valuable tools for evaluation of new therapeutic strategies for secondary liver cancers. J Biomed Biotechnol 2009: 437284-437296.
4. Law LW (1954) Recent advances in experimental leukemia research. Cancer Res 14: 695-709.
5. Povlsen CO, Rygaard J (1972) Heterotransplantation of human epidermoid carcinomas to the mouse mutant nude. Acta Pathol Microbiol Scand A 80: 713-717.
6. Skakkebaek NE, Jensen G, Povlsen CO, Rygaard J (1974) Heterotransplantation of human foetal testicular and ovarian tissue to the mouse mutant nude. A preliminary study. Acta Obstet Gynecol Scand 29: 73-75.
7. Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, et al. (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84: 1424-1431. (Pubitemid 32522115)
8. Damia G, D'Incalci M (2009) Contemporary pre-clinical development of anticancer agents-what are the optimal preclinical models? Eur J Cancer 45: 2768-2781.
9. Skovseth DK, Yamanaka T, Brandtzaeg P, Butcher EC, Haraldsen G (2002) Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodeficient mice. Am J Pathol 160: 1629-1637. (Pubitemid 34525643)
10. Koike N, Fukumura D, Gralla O, Au P, Schechner JS, et al. (2004) Tissue engineering: creation of long-lasting blood vessels. Nature 428: 138-139. (Pubitemid 38374298)
11. Enis DR, Shepherd BR, Wang Y, Qasim A, Shanahan CM, et al. (2005) Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. Proc Natl Acad Sci USA 102: 425-430. (Pubitemid 40116783)
12. Sanz L, Cuesta AM, Salas C, Corbacho C, Bellas C, et al. (2008) Differential transplantability of human endothelial cells in colorectal cancer and renal cell carcinoma primary xenografts. Lab Invest 89: 91-97.
13. Nör JE, Peters MC, Christensen JB, Sutorik MM, Linn S, et al. (2001) Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 81: 453-463. (Pubitemid 32298790)
14. Zeng Q, Li S, Chepeha BD, Giordano TJ, Li J, et al. (2005) Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8: 13-23. (Pubitemid 40991811)
15. Zeitlin BD, Joo E, Dong Z, Warner K, Wang G, et al. (2006) Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2. Cancer Res 66: 8698-8706. (Pubitemid 44449186)
16. Dong Z, Neiva KG, Jin T, Zhang Z, Hall DE, et al. (2007) Quantification of human angiogenesis in immunodeficient mice using a photon counting-based method. Biotechniques 43: 73-77. (Pubitemid 47092755)
17. Dong Z, Zeitlin BD, Song W, Sun Q, Karl E, et al. (2007) Level of endothelial cell apoptosis required for a significant decrease in microvessel density. Exp Cell Res 313: 3645-3657. (Pubitemid 47411573)
18. Nör JE, Christensen J, Liu J, Peters M, Mooney DJ, et al. (2001) Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 61: 2183-2188. (Pubitemid 32692045)
19. Kaneko T, Zhang Z, Mantellini MG, Karl E, Zeitlin B, et al. (2007) Bcl-2 orchestrates a crosstalk between endothelial and tumor cells that promotes tumor growth. Cancer Res 67: 9685-9693. (Pubitemid 47621215)
20. L and Bcl-2 enhances the angiogenic phenotype of endothelial cells. Cell Death Differ 14: 1657-1666.
21. Warner KA, Miyazawa M, Cordeiro MM, Love WJ, Pinsky MS, et al. (2008) Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling. Neoplasia 10: 131-139. (Pubitemid 351240879)
22. Neiva KG, Zhang Z, Miyazawa M, Warner KA, Karl E, et al. (2009) Crosstalk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia 11: 583-593.
23. Nör JE, Christensen J, Mooney DJ, Polverini PJ (1999) Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154: 375-384. (Pubitemid 29094088)
24. Karl E, Warner K, Zeitlin BD, Kaneko T, Wurtzel L, et al. (2005) Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines. Cancer Res 65: 5063-5069. (Pubitemid 40827314)
25. Watanabe K, Lida M, Takaishi K, Suzuki T, Hamada Y, et al. (1993) Chemoattractants for neutrophils in lipopolysaccharide-induced inflammatory exudate from rats are not interleukin-8 counterparts but gro-gene-product/ melanoma-growth-stimulating-activity-related factors. Eur J Biochem 214: 267-270. (Pubitemid 23168542)
26. Yoshimura T, Johnson DG (1993) cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1). NAP-1 is highly conserved in guinea pig. J Immunol 151: 6225-6236. (Pubitemid 23340368)
27. Richmond A (2002) Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2: 664-674.
28. DiDonato JA, Mercurio F, Karin M (2012) NF-κB and the link between inflammation and cancer. Immunol Rev 246: 379-400.
29. Arkan MC, Greten FR (2011) IKK- and NF-κB-mediated functions in carcinogenesis. Curr Top Microbiol Immunol 349: 159-69.
30. Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, et al (2012) Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol 9: 338-50.